Papa presented the company’s “turnaround plan” for 2025 at J.P. Morgan. “We are focused on first stabilising the company, ...

Emergent BioSolutions (NYSE:EBS – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Friday. Several other equities ...

Jan. 14, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today tha This option is part of Emergent’s existing 10-year contract with BARDA for advanced development and ...

Emergent BioSolutions Inc. (EBS) stock price is 11.19 and Emergent BioSolutions Inc. (EBS) 10-day simple moving average is 10.22. Emergent BioSolutions Inc. (EBS) stock price is 11.19 and Emergent ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

View Emergent BioSolutions Inc. (EBS) current and estimated P/E ratio data provided by Seeking Alpha.

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on ImmunoPrecise Antibodies (IPA – Research ...

Emergent BioSolutions has been given FDA approval to extend the indications for its smallpox vaccine ACAM2000 to include the prevention of mpox, currently deemed a public health emergency by the WHO.

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

After hours: January 24 at 7:54:08 p.m. EST ...

LONDON, GREATER LONDON, UNITED KINGDOM, January 25, 2025 /EINPresswire / -- The ebanga market size has seen significant historical compound annual growth, growing from millions in 2024 to a higher ...